← Back to Clinical Trials
Recruiting Phase 3 NCT05827042

Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion

Trial Parameters

Condition Basilar Artery Occlusion
Sponsor The First Affiliated Hospital of University of Science and Technology of China
Study Type INTERVENTIONAL
Phase Phase 3
Enrollment 338
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-05-09
Completion 2025-12-31
Interventions
Intravenous thrombolysisEndovascular thrombectomy

Brief Summary

To assess the effect of endovascular thrombectomy alone compared to intravenous thrombolysis plus endovascular thrombectomy in acute basilar artery occlusion patients within 4.5 hours from onset on efficacy and safety outcomes.

Eligibility Criteria

Inclusion Criteria: 1. Patients presenting with posterior circulation ischemic stroke symptoms due to basilar artery occlusion or vertebral artery occlusions that prevent antegrade flow into the basilar artery; 2. Time from stroke onset to randomization within 4.5 hours of estimated time of basilar artery occlusion; 3. Patient's age ≥ 18 years; 4. Presence of basilar artery or vertebral artery occlusion, confirmed by CT Angiography (CTA), MR Angiography (MRA) or Digital Subtraction Angiography (DSA). In case of vertebral artery occlusion, the occlusion must completely prevent antegrade flow into the basilar artery; 5. Patients presenting with acute ischemic stroke eligible to receive both endovascular thrombectomy and intravenous thrombolysis using standard criteria; 6. Baseline National Institutes of Health Stroke Scale (NIHSS) score ≥ 10; 7. The patient or patient's legal representative signs the informed consent form. Exclusion Criteria: 1. CT or MR evidence of intracerebral hemorrh

Related Trials